Hormone Receptor Positive Tumor Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03409198Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast CancerTreatment